Deals
Aspen Seeks Drugs Acquisitions as Overseas Deals Fuel Growth
- South African group looks to expand infant nutrition overseas
- Shares gain most in almost four months in Johannesburg trading
This article is for subscribers only.
Aspen Pharmacare Holdings Ltd., Africa’s largest generic-drugs maker, is looking for acquisitions and seeking to expand its infant nutrition business after international sales boosted full-year profit.
The Durban, South Africa-based company, which supplies medicines in more than 150 countries, is seeking purchases in China, Japan and Southeast Asia, Deputy Chief Executive Officer Gus Attridge said by phone on Wednesday. While Aspen “won’t walk away from any great opportunity,” the company is seeking to expand its infant-milk, anti-coagulant and women’s-health units, he said.